The biological role of the enzymes and other proteins involved in the establishment of the targeted modifications was then validated with the aid of pharmacological inhibitors and RNAi in LX-2 and GIST-T1 cells using KITLG expression as readout. Here, KITLG is linked to gastrointestinal stromal tumor.